Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit

AIMS: The long-term disposition of tacrolimus following kidney transplantation is characterized by a gradual decrease in dose requirements and increase in dose-corrected exposure. This phenomenon has been attributed to a progressive decline in cytochrome P450 3A4 (CYP3A4) activity, although this has...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Br J Clin Pharmacol
Auteurs principaux: de Jonge, Hylke, Vanhove, Thomas, de Loor, Henriëtte, Verbeke, Kristin, Kuypers, Dirk R J
Format: Artigo
Langue:Inglês
Publié: John Wiley & Sons, Ltd 2015
Sujets:
Pharmacokinetics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4574839/
https://ncbi.nlm.nih.gov/pubmed/26114223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12703
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires